
In Stock
Vancouver, BC lab partner
10 vials per kit
30 CAD shipping within Canada. Adding Amino Blends adds a separate 30 CAD shipping fee.
| Product / strength | Pack | Price (CAD) | Availability | Report |
|---|---|---|---|---|
| Tirzepatide 10 mg | 10 vials | $180.00 | In Stock | Not published for this option |
| Tirzepatide 20 mg | 10 vials | $270.00 | In Stock | 20 mg PDF |
Tirzepatide Canada: available through Vancouver Island Peptides, synthesized domestically at our Vancouver, BC lab partner. Our Tirzepatide in Canada is produced locally, not sourced from overseas and repackaged. Research-grade purity, full traceability, shipped discreetly Canada-wide.
Available in 10mg and 20mg lyophilized powder vials.
Tirzepatide is a synthetic peptide and dual GLP-1/GIP receptor agonist that has become one of the most studied metabolic research compounds in the world. By simultaneously targeting two complementary hormone receptors, Tirzepatide produces effects on appetite regulation, insulin sensitivity, and metabolic rate that exceed single-agonist compounds like Semaglutide.
As a domestic peptide in Canada, our Tirzepatide is produced under the same strict quality standards as all Vancouver Island Peptides compounds, synthesized in British Columbia, not imported.
The dual mechanism is what distinguishes Tirzepatide from earlier single-agonist GLP-1 compounds, and it remains the established benchmark for dual-agonist metabolic research in Canada and globally.
| Product Name | Tirzepatide |
| Format | Lyophilized Powder |
| Available Sizes | 10mg, 20mg |
| Purity | See the published report for the exact compound and strength |
| Storage | −20°C, away from light |
| Origin | Domestic (Vancouver, BC, Canada) |
| Shipping | Canada-wide, discreet packaging |
| Payment | Interac e-Transfer for orders under $500; BTC or USDC (on Ethereum) for orders of $500 and over |
Both are available as domestic peptides Canada through Vancouver Island Peptides. Tirzepatide is the established dual-agonist with the longer research history. Retatrutide extends this with a third receptor target (glucagon), offering broader metabolic coverage. Researchers often start with Tirzepatide as the baseline comparator.
View Tirzepatide on the Store